###begin article-title 0
###xml 23 31 <span type="species:ncbi:9606">Patients</span>
Serum Leptin Levels in Patients with Ocular and Nonocular Behcet's Disease
###end article-title 0
###begin p 1
This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
###end p 1
###begin p 2
###xml 0 4 0 4 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Aims</italic>
###xml 228 235 228 235 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Methods</italic>
###xml 568 575 568 575 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Results</italic>
###xml 703 704 703 704 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 735 736 735 736 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 886 887 886 887 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 999 1000 999 1000 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 1009 1020 1009 1020 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Conclusions</italic>
###xml 53 61 <span type="species:ncbi:9606">patients</span>
###xml 194 202 <span type="species:ncbi:9606">patients</span>
###xml 249 257 <span type="species:ncbi:9606">patients</span>
###xml 350 358 <span type="species:ncbi:9606">patients</span>
###xml 624 632 <span type="species:ncbi:9606">patients</span>
###xml 789 797 <span type="species:ncbi:9606">patients</span>
###xml 944 952 <span type="species:ncbi:9606">patients</span>
Aims. To investigate serum leptin levels in Behcet's patients with or without ocular involvement compared with healthy subjects and the relationship between serum leptin and uveitis activity in patients with ocular involvement. Methods. Fifty-seven patients with Behcet's disease and 20 healthy control subjects were included in this study. While 27 patients had ocular involvement (18 had acute uveitis, 9 had inactive ocular involvement), 30 did not have ocular disease. C-reactive protein, alpha 1-antitrypsin, and serum leptin levels were measured in all samples. Results. There was a significant difference between the patients with Behcet's disease and control group for both logarithm of leptin (P = .000) and logarithm of CRP (P = .031). Logarithm of leptin in non-ocular Behcet's patients was significantly higher compared to its level in ocular Behcet's disease and controls (P = .009). There was a significant difference between the patients with active ocular disease and control group (P = .03). Conclusions. Leptin might have a possible role in the pathogenesis of Behcet's disease.
###end p 2
###begin title 3
1. INTRODUCTION
###end title 3
###begin p 4
###xml 119 120 119 120 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B1">1</xref>
###xml 487 488 487 488 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B2">2</xref>
###xml 562 566 562 563 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#946;</italic>
###xml 640 641 637 638 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B3">3</xref>
###xml 608 616 <span type="species:ncbi:9606">patients</span>
Behcet's disease is a chronic, systemic inflammatory disorder affecting multiple organs with a generalized vasculitis [1]. The etiology and pathogenesis of Behcet's disease have not been entirely enlightened. The main immunological features of Behcet's disease consist of increased T- and B-cell responses to heat-shock proteins, increased neutrophil activity, and alterations in cytokine levels, although the interrelationships between and among these features have not been clarified [2]. Serum levels of neutrophil priming cytokines such as TNF, interleukin-1beta, and IL-8 are determined to be raised in patients with Behcet's disease [3].
###end p 4
###begin p 5
###xml 98 99 98 99 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B4">4</xref>
###xml 100 101 100 101 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B6">6</xref>
###xml 188 189 188 189 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B7">7</xref>
###xml 276 277 276 277 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B8">8</xref>
###xml 279 280 279 280 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B9">9</xref>
###xml 350 352 350 352 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B10">10</xref>
Leptin is a peptide hormone that regulates body weight as well as endocrine and immune functions [4-6]. Leptin has structural and functional similarities with members of cytokines family [7]. The leptin receptor is homologous to a subunit of the IL-6-type cytokine receptors [8, 9]. Leptin shares the same signal transduction pathway with cytokines [10].
###end p 5
###begin p 6
###xml 434 439 434 435 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#945;</italic>
###xml 156 164 <span type="species:ncbi:9606">patients</span>
###xml 297 305 <span type="species:ncbi:9606">patients</span>
In light of the fact that leptin might participate in the host response to inflammation, we aimed to investigate changes of serum leptin levels in Behcet's patients with or without ocular involvement compared with healthy subjects and the relationship between serum leptin and uveitis activity in patients with ocular involvement. We compared serum leptin changes with other acute phase reactants, such as CRP or alpha-1 antitrypsin (alpha1-antitrypsin).
###end p 6
###begin title 7
2. MATERIAL AND METHODS
###end title 7
###begin p 8
###xml 171 173 171 173 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B11">11</xref>
###xml 12 20 <span type="species:ncbi:9606">patients</span>
###xml 76 84 <span type="species:ncbi:9606">patients</span>
###xml 295 303 <span type="species:ncbi:9606">patients</span>
###xml 374 382 <span type="species:ncbi:9606">patients</span>
###xml 573 581 <span type="species:ncbi:9606">patients</span>
###xml 718 726 <span type="species:ncbi:9606">patients</span>
###xml 1020 1032 <span type="species:ncbi:9606">participants</span>
Fifty-seven patients with Behcet's disease were included in this study. All patients included in the study met the international diagnostic criteria for Behcet's disease [11]. A complete ophthalmologic examination was performed by ophthalmologists with an interest in Behcet's disease. While 27 patients had ocular involvement, the other 30 did not have ocular disease. All patients with ocular involvement were split into two groups according to the activation of eye involvement to investigate the association between leptin levels and ocular disease activity. Of the 27 patients who had ocular disease, 18 suffered acute uveitis and 9 had inactive ocular involvement at the time of enrollment. None of the Behcet's patients were on systemic steroids or immunosuppressant agents. Twenty healthy control subjects were also included in the study. The subjects who had any systemic or ocular disease were excluded. The subjects were matched for age, sex, and body mass index (BMI). Informed consent was obtained from all participants.
###end p 8
###begin p 9
###xml 42 49 <span type="species:ncbi:9606">patient</span>
A venous blood sample was taken from each patient and control subject between 8.00 a.m. and 10:00 a.m. after an overnight fast. The blood samples were centrifugated to obtain serum. All serum samples were immediately stored at -80degreesC until use.
###end p 9
###begin p 10
###xml 26 31 26 27 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#945;</italic>
###xml 123 128 119 120 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#945;</italic>
C-reactive protein (CRP), alpha1-antitrypsin, and serum leptin levels were measured in all samples. C-reactive protein and alpha1-antitrypsin levels were measured by the immunoturbidimetric method using commercial kit (Roche Mannheim, Germany) on P 800 autoanalyzer (Roche). Serum samples were assayed for leptin, using enzyme-amplified sensitivity immunoassay kit (Biosource Europe S.A., Nivelles, Belgium).
###end p 10
###begin p 11
###xml 103 108 103 104 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#945;</italic>
Serum leptin levels were compared with those measurings of other acute phase reactants, such as CRP or alpha1-antitrypsin.
###end p 11
###begin title 12
2.1. Statistics
###end title 12
###begin p 13
###xml 240 241 240 241 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">t</italic>
###xml 456 457 456 457 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">U</italic>
###xml 271 279 <span type="species:ncbi:9606">patients</span>
###xml 368 376 <span type="species:ncbi:9606">patients</span>
###xml 401 409 <span type="species:ncbi:9606">patients</span>
###xml 508 516 <span type="species:ncbi:9606">patients</span>
###xml 547 555 <span type="species:ncbi:9606">patients</span>
###xml 576 584 <span type="species:ncbi:9606">patients</span>
Statistical analysis was performed using SPSS 13.0 software for Windows. As the data were not normally distributed, logarithmic values of CRP (log CRP) and leptin (log leptin) levels were used. Statistical analysis was performed by Student t test to compare all Behcet's patients with controls. ANOVA and post hoc test (Tukey HSD) were used to compare ocular Behcet's patients with nonocular Behcet's patients and controls. Kruskal-Wallis and Mann-Whitney U tests were used to compare active ocular Behcet's patients with inactive ocular Behcet's patients, nonocular Behcet's patients, and controls.
###end p 13
###begin p 14
###xml 305 306 303 304 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 150 158 <span type="species:ncbi:9606">patients</span>
Pearson's correlation test was used for evaluating the correlation between different parameters in all groups, apart from the group consisting of the patients with inactive eye involvement. Spearman's correlation analysis was used for evaluating that group. Data were presented as mean +/- SD. A value of P < .05 was considered significant.
###end p 14
###begin title 15
3. RESULTS
###end title 15
###begin p 16
###xml 64 71 64 71 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="T1">Table 1</xref>
###xml 273 274 273 274 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 296 297 296 297 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 437 438 437 438 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 658 659 658 659 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 0 7 <span type="species:ncbi:9606">Patient</span>
###xml 83 91 <span type="species:ncbi:9606">patients</span>
###xml 203 211 <span type="species:ncbi:9606">patients</span>
###xml 340 348 <span type="species:ncbi:9606">patients</span>
###xml 485 493 <span type="species:ncbi:9606">patients</span>
###xml 594 602 <span type="species:ncbi:9606">patients</span>
Patient characteristics and laboratory findings are outlined in Table 1. Of the 57 patients in this study, 28 were male (49.1%) and 29 were female (50.9%). There was a significant difference between the patients with Behcet's disease and control group for both log leptin (P = .000) and log CRP (P = .031). Log leptin in nonocular Behcet's patients was significantly higher compared to its level in ocular Behcet's disease and controls (P = .009). Log leptin was not different between patients with ocular and nonocular Behcet's disease. However, there was a significant difference between the patients with active ocular Behcet's disease and control group (P = .03).
###end p 16
###begin p 17
###xml 71 72 71 72 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">r</italic>
###xml 80 81 80 81 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 95 100 95 96 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#945;</italic>
###xml 143 144 139 140 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">r</italic>
###xml 152 153 148 149 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 242 247 238 239 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#945;</italic>
###xml 318 323 310 311 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#945;</italic>
###xml 366 367 354 355 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">r</italic>
###xml 375 376 363 364 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 426 427 414 415 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">r</italic>
###xml 436 437 424 425 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 489 494 477 478 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#945;</italic>
###xml 537 538 521 522 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">r</italic>
###xml 546 547 530 531 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 606 611 590 591 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#945;</italic>
###xml 654 655 634 635 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">r</italic>
###xml 663 664 643 644 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 761 762 741 742 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">r</italic>
###xml 770 771 750 751 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 785 790 765 766 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#945;</italic>
###xml 833 834 809 810 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">r</italic>
###xml 842 843 818 819 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 931 936 907 908 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#945;</italic>
###xml 3 11 <span type="species:ncbi:9606">patients</span>
###xml 276 284 <span type="species:ncbi:9606">patients</span>
###xml 450 458 <span type="species:ncbi:9606">patients</span>
###xml 560 568 <span type="species:ncbi:9606">patients</span>
###xml 677 685 <span type="species:ncbi:9606">patients</span>
In patients with Behcet's disease, log leptin was correlated with BMI (r = .44, P = .001), and alpha1-antitrypsin was correlated with log CRP (r = .61, P = .000). On the other hand, there was no significant correlation between log leptin and alpha1-antitrypsin or log CRP. In patients with nonocular Behcet's disease, alpha1-antitrypsin was correlated with log CRP (r = .56, P = .002), and log leptin was correlated with BMI (r = .052, P = .004). In patients with ocular Behcet's disease, alpha1-antitrypsin was correlated with log CRP (r = .73, P = .000). In patients with active ocular Behcet's disease, alpha1-antitrypsin was correlated with log CRP (r = .79, P = .000). In patients with inactive ocular Behcet's disease, log leptin was correlated with BMI (r = .86, P = .007), and alpha1-antitrypsin was correlated with log CRP (r = .81, P = .014). In control group, there was no significant correlation between log leptin and alpha1-antitrypsin or BMI and log CRP.
###end p 17
###begin title 18
4. DISCUSSION
###end title 18
###begin p 19
###xml 178 180 178 180 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B12">12</xref>
Leptin is primarily produced by adipose tissue. Leptin levels in the systemic circulation are controlled by a variety of factors, especially food intakeand the endocrine system [12]. The innate immune system also participates in the regulation of leptin production.
###end p 19
###begin p 20
###xml 220 225 220 221 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#945;</italic>
###xml 231 236 227 228 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#945;</italic>
###xml 264 265 256 257 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B5">5</xref>
###xml 267 269 259 261 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B13">13</xref>
###xml 392 394 384 386 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B14">14</xref>
In experimental animals, leptin levels are acutely increased after administration of the inflammatory stimulus such as lipopolysaccharide (LPS) and turpentine, and proinflammatory cytokines such as tumor necrosis factor-alpha (TNF-alpha) and interleukin-1 (IL-1) [5, 13]. The kinetics of leptinproduction during infectious and inflammatory processes is similar to that of cytokine induction [14].
###end p 20
###begin p 21
###xml 157 161 157 158 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#946;</italic>
###xml 169 174 166 167 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#945;</italic>
###xml 237 239 230 232 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B15">15</xref>
###xml 241 243 234 236 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B16">16</xref>
###xml 331 333 324 326 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B17">17</xref>
###xml 445 447 438 440 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B18">18</xref>
###xml 627 629 620 622 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B19">19</xref>
###xml 631 633 624 626 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B20">20</xref>
###xml 17 22 <span type="species:ncbi:9606">human</span>
###xml 323 329 <span type="species:ncbi:9606">humans</span>
Data obtained in human studies regarding the regulation of leptin expression in response to infection and inflammation are varied. The administration of IL-1beta or TNF-alpha results in increased serum leptin levels in healthy subjects [15, 16]. However, no increase in serum leptin levels was found after LPS injection to humans [17]. Leptin concentrations were found to be elevated during an acute inflammatory stimulus such as major surgery [18]. Nevertheless, in the chronic phase of inflammatory diseases such as rheumatoid arthritis and inflammatory bowel disease, inflammation-associated leptin peaks were not observed [19, 20].
###end p 21
###begin p 22
###xml 190 191 190 191 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B3">3</xref>
###xml 192 194 192 194 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B21">21</xref>
###xml 307 309 307 309 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B22">22</xref>
###xml 432 434 432 434 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B22">22</xref>
###xml 613 615 613 615 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B23">23</xref>
###xml 257 265 <span type="species:ncbi:9606">patients</span>
###xml 332 340 <span type="species:ncbi:9606">patients</span>
###xml 669 677 <span type="species:ncbi:9606">patients</span>
###xml 804 812 <span type="species:ncbi:9606">patients</span>
###xml 885 893 <span type="species:ncbi:9606">patients</span>
###xml 1086 1094 <span type="species:ncbi:9606">patients</span>
###xml 1204 1212 <span type="species:ncbi:9606">patients</span>
###xml 1363 1371 <span type="species:ncbi:9606">patients</span>
Although the etiology and pathogenesis of Behcet's disease are not clear, increased serum levels of inflammatory cytokines have been established to correlate with Behcet's disease activity [3-21]. A correlation between leptin levels and disease activity in patients with Behcet's disease has been reported [22]. Leptin levels in 35 patients with Behcet's disease were also found to be higher than in healthy controls in that study [22]. In another study, 28 males with ocular Behcet's disease were compared with 15 healthy controls, and serum levels of leptin were not significantly different between the groups [23]. In that study, leptin levels were compared between patients with ocular Behcet's disease and healthy subjects; whereas, we compared leptin levels between the groups composed of Behcet's patients with and without ocular involvement and healthy subjects. In our study, patients with Behcet's disease with or without ocular involvement were found to have higher serum leptin and CRP levels compared according to age-, sex-, and BMI-matched controls. However, in Behcet's patients with ocular involvement, serum leptin concentrations were not significantly different from those in Behcet's patients without ocular involvement in our study. The results of our study also demonstrated that the mean serum leptin levels were significantly increased in patients with active uveitis compared to control subjects.
###end p 22
###begin p 23
Because serum leptin levels are closely associated with the amount of body fat and differ between males and females, BMI- and sex-matched subjects were enrolled in the groups. The subjects were on systemic steroids or immunosuppressive agents were not included in the study to avoid the possible effects of these agents on the serum leptin levels.
###end p 23
###begin p 24
###xml 49 57 <span type="species:ncbi:9606">patients</span>
In conclusion, the higher serum leptin levels in patients with Behcet's disease compared to control subjects in the present study might be attributed to a possible role for leptin in the pathogenesis of Behcet's disease. Elevated serum leptin level does not seem to be a risk factor in ocular involvement. However, there might be a correlation between leptin levels and uveitis activity. Future studies would be useful to clarify the potential influence of leptin in Behcet's disease.
###end p 24
###begin title 25
ACKNOWLEDGMENTS
###end title 25
###begin p 26
We gratefully acknowledge the excellent technical assistance of Fatos Ozyalcin and Emine Uluyuz.
###end p 26
###begin article-title 27
Behcet's disease: an immune-mediated vasculitis involving vessels of all sizes
###end article-title 27
###begin article-title 28
Behcet's disease: a review
###end article-title 28
###begin article-title 29
###xml 57 62 57 58 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#945;</italic>
Overproduction of monocyte derived tumor necrosis factor alpha, interleukin (IL) 6, IL-8 and increased neutrophil superoxide generation in Behcet's disease. A comparative study with familial Mediterranean fever and healthy subjects
###end article-title 29
###begin article-title 30
Leptin
###end article-title 30
###begin article-title 31
Leptin in the regulation of immunity, inflammation, and hematopoiesis
###end article-title 31
###begin article-title 32
A role for leptin in rheumatic diseases?
###end article-title 32
###begin article-title 33
Crystal structure of the obese protein leptin-E100
###end article-title 33
###begin article-title 34
Identification and expression cloning of a leptin receptor, OB-R
###end article-title 34
###begin article-title 35
###xml 30 33 <span type="species:ncbi:9606">men</span>
Serum leptin levels in septic men correlate well with C-reactive protein (CRP) and TNF-alpha but not with BMI
###end article-title 35
###begin article-title 36
The full-length leptin receptor has signaling capabilities of interleukin 6-type cytokine receptors
###end article-title 36
###begin article-title 37
Criteria for diagnosis of Behcet's disease
###end article-title 37
###begin article-title 38
Leptin and the regulation of body weight in mammals
###end article-title 38
###begin article-title 39
Leptin regulates proinflammatory immune responses
###end article-title 39
###begin article-title 40
###xml 48 53 <span type="species:ncbi:10090">mouse</span>
Multiple cytokines and acute inflammation raise mouse leptin levels: potential role in inflammatory anorexia
###end article-title 40
###begin article-title 41
###xml 13 18 13 14 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#945;</italic>
###xml 60 66 <span type="species:ncbi:9606">humans</span>
Interleukin 1alpha increases serum leptin concentrations in humans
###end article-title 41
###begin article-title 42
###xml 55 61 <span type="species:ncbi:9606">humans</span>
Tumor necrosis factor increases serum leptin levels in humans
###end article-title 42
###begin article-title 43
###xml 96 102 <span type="species:ncbi:9606">humans</span>
Circulating leptin levels during acute experimental endotoxemia and antiinflammatory therapy in humans
###end article-title 43
###begin article-title 44
The coordinated cytokine/hormone response to acute injury incorporates leptin
###end article-title 44
###begin article-title 45
###xml 64 72 <span type="species:ncbi:9606">patients</span>
Leptin serum levels are not correlated with disease activity in patients with rheumatoid arthritis
###end article-title 45
###begin article-title 46
###xml 16 24 <span type="species:ncbi:9606">children</span>
Serum leptin in children and young adults with inflammatory bowel disease
###end article-title 46
###begin article-title 47
Systemic levels of the T cell regulatory cytokines IL-10 and IL-12 in Behcet's disease; soluble TNFR-75 as a biological marker of disease activity
###end article-title 47
###begin article-title 48
###xml 43 51 <span type="species:ncbi:9606">patients</span>
Serum leptin concentration is increased in patients with Behcet's syndrome and is correlated with disease activity
###end article-title 48
###begin article-title 49
Evaluation of serum leptin concentration in Behcet's disease with ocular involvement
###end article-title 49
###begin p 50
###xml 0 7 <span type="species:ncbi:9606">Patient</span>
###xml 48 56 <span type="species:ncbi:9606">patients</span>
Patient demographics and laboratory findings in patients with ocular and nonocular Behcet's disease and controls.
###end p 50

